Imaging neoadjuvant therapy response in breast cancer

AM Fowler, DA Mankoff, BN Joe - Radiology, 2017 - pubs.rsna.org
The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Neoadjuvant chemotherapy in breast cancers

S Masood - Women's Health, 2016 - journals.sagepub.com
With advances in science and technology, there are more innovations in the approach to
management of patients with breast cancer. Neoadjuvant chemotherapy that is designed to …

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

RFD Van la Parra, HM Kuerer - Breast Cancer Research, 2016 - Springer
With improvements in chemotherapy regimens, targeted therapies, and our fundamental
understanding of the relationship of tumor subtype and pathologic complete response …

[HTML][HTML] Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?

M Faruk - Annals of Medicine and Surgery, 2021 - Elsevier
Chemotherapy is an essential treatment for breast cancer, inducing cancer cell death.
However, chemoresistance is a problem that limits the effectiveness of chemotherapy. Many …

Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer

GM Rauch, BE Adrada, HM Kuerer… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. Neoadjuvant chemotherapy is becoming the standard of care for patients with
locally advanced breast cancer. Conventional imaging modalities used for the assessment …

Role of imaging in neoadjuvant therapy for breast cancer

V Dialani, T Chadashvili, PJ Slanetz - Annals of surgical oncology, 2015 - Springer
Neoadjuvant chemotherapy (NAC) involves administration of chemotherapeutic agents to
patients with newly diagnosed breast cancer prior to definitive surgical treatment …

ACR appropriateness criteria® monitoring response to neoadjuvant systemic therapy for breast cancer

PJ Slanetz, L Moy, P Baron, ED Green, SL Heller… - Journal of the American …, 2017 - Elsevier
Patients with locally advanced invasive breast cancers are often treated with neoadjuvant
chemotherapy prior to definitive surgical intervention. The primary aims of this approach are …

Staging breast cancer with MRI, the T. A key role in the neoadjuvant setting

C Panico, F Ferrara, R Woitek, A D'Angelo, V Di Paola… - Cancers, 2022 - mdpi.com
Simple Summary Neoadjuvant chemotherapy (NACT) indications have expanded from
inoperable locally advanced to early-stage breast cancer. The pivotal role of magnetic …

[HTML][HTML] Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

J Heil, B Schaefgen, P Sinn, H Richter, A Harcos… - European Journal of …, 2016 - Elsevier
Background This study aimed to explore the ability of a minimal invasive biopsy to diagnose
a pathological complete response (pCR= ypT0) in the breast. Methods Ultrasound-guided …

TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs

F Wang, Z Zou, N Sakla, L Partyka, N Rawal… - Medical Image …, 2025 - Elsevier
Abstract Characterization of breast parenchyma in dynamic contrast-enhanced magnetic
resonance imaging (DCE-MRI) is a challenging task owing to the complexity of underlying …